Yang H - Search Results

1

Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.

Meng X, Li Y, Tang H, Mao W, Yang H, Wang X, Ding X, Xie S. Meng X, et al. Among authors: yang h. Amino Acids. 2016 Feb;48(2):487-97. doi: 10.1007/s00726-015-2102-2. Epub 2015 Oct 6. Amino Acids. 2016. PMID: 26439378

2

[Study on cancer incidence through the cancer registry program in 11 cities and counties, China].

Lei T, Mao WM, Yang HJ, Chen XZ, Lei TH, Wang XH, Ying Q, Chen WQ, Zhang SW. Lei T, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Nov;30(11):1165-70. Zhonghua Liu Xing Bing Xue Za Zhi. 2009. PMID: 20193588 Chinese.

3

Unilateral hemilaminectomy for patients with intradural extramedullary tumors.

Sun CX, Meng XL, Xie SN, Yu Y, Yang HJ, Wu B. Sun CX, et al. J Zhejiang Univ Sci B. 2011 Jul;12(7):575-81. doi: 10.1631/jzus.B1000402. J Zhejiang Univ Sci B. 2011. PMID: 21726065 Free PMC article.

4

Possible role of Pax-6 in promoting breast cancer cell proliferation and tumorigenesis.

Zong X, Yang H, Yu Y, Zou D, Ling Z, He X, Meng X. Zong X, et al. Among authors: yang h. BMB Rep. 2011 Sep;44(9):595-600. doi: 10.5483/bmbrep.2011.44.9.595. BMB Rep. 2011. PMID: 21944253 Free article.

5

Low expression of stathmin in tumor predicts high response to neoadjuvant chemotherapy with docetaxel-containing regimens in locally advanced breast cancer.

Meng XL, Su D, Wang L, Gao Y, Hu YJ, Yang HJ, Xie SN. Meng XL, et al. Genet Test Mol Biomarkers. 2012 Jul;16(7):689-94. doi: 10.1089/gtmb.2011.0298. Epub 2012 Apr 5. Genet Test Mol Biomarkers. 2012. PMID: 22480216 Free PMC article. Clinical Trial.

6

BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer.

Cao W, Wang X, Gao Y, Yang H, Li JC. Cao W, et al. Among authors: yang h. Anat Rec (Hoboken). 2013 Feb;296(2):273-8. doi: 10.1002/ar.22628. Epub 2012 Nov 23. Anat Rec (Hoboken). 2013. PMID: 23175448 Free article.

7

A support vector machine model for predicting non-sentinel lymph node status in patients with sentinel lymph node positive breast cancer.

Ding X, Xie S, Chen J, Mo W, Yang H. Ding X, et al. Among authors: yang h. Tumour Biol. 2013 Jun;34(3):1547-52. doi: 10.1007/s13277-013-0683-5. Epub 2013 Feb 10. Tumour Biol. 2013. PMID: 23397544

8

Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: a retrospective cohort study.

Sun CX, Li T, Zheng X, Cai JF, Meng XL, Yang HJ, Wang Z. Sun CX, et al. Chin J Cancer Res. 2011 Sep;23(3):177-82. doi: 10.1007/s11670-011-0177-1. Chin J Cancer Res. 2011. PMID: 23467694 Free PMC article.

9

The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.

Xu XL, Chen SZ, Chen W, Zheng WH, Xia XH, Yang HJ, Li B, Mao WM. Xu XL, et al. Breast Cancer Res Treat. 2013 Jun;139(2):329-39. doi: 10.1007/s10549-013-2563-5. Epub 2013 May 14. Breast Cancer Res Treat. 2013. PMID: 23670132

10

Overexpression of ILK1 in breast cancer associates with poor prognosis.

Yang HJ, Zheng YB, Ji T, Ding XF, Zhu C, Yu XF, Ling ZQ. Yang HJ, et al. Tumour Biol. 2013 Dec;34(6):3933-8. doi: 10.1007/s13277-013-0981-y. Epub 2013 Jul 7. Tumour Biol. 2013. PMID: 23832543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,467 results

Search Page

Filters